Anzeige
❌
Mehr »
Donnerstag, 01.10.2026 - Börsentäglich über 12.000 News
Dieselbe Arbeit, dieselbe Rechnung, der vierfache Bruttogewinn
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
10:54Samsung Bioepis, Teva partner on biosimilar candidates
10:54Hercules announces CFO succession as Wheatcroft retires
10:54Marechale Capital schedules AGM for Oct. 26 in London
10:54BMO Capital downgrades Sigma Lithium stock rating on legal concerns
10:54Oppenheimer initiates Vita Coco stock coverage with outperform rating
10:54Barclays reinstates Williams Companies stock rating at overweight
10:30Persimmon issues 37,736 shares for employee schemes
10:30Rothschild Redburn downgrades Hermes stock rating on China concerns
10:18Grande Portage secures gold offtake deal with Ocean Partners
10:18Thungela executives receive dividend equivalent shares
10:18Kaufman & Broad 9M 2026 slides: margins hold amid French housing slump
10:18KeyBanc reiterates Micron Technology stock rating on strong demand
10:18Wedbush reiterates Micron stock rating on tight supply outlook
10:18Rosenblatt raises Micron stock price target on margin outlook
10:18BMO reiterates Micron stock rating on strong demand outlook
09:54Arqiva appoints Simon Duffy as board chair
09:54Mizuho raises Micron stock price target to $1,400 on AI strength
09:54Raymond James reiterates Micron stock rating on strong demand outlook
09:54Melius reiterates Micron stock Buy rating on tighter supply outlook
09:54RBC Capital reiterates Micron stock rating on supply outlook
09:54Barclays initiates Amrize stock with Equalweight rating
09:54Roth/MKM initiates Civeo stock with buy rating on valuation gap
09:54JPMorgan initiates Spyre stock with Overweight on IBD pipeline
09:54JPMorgan initiates Kura Oncology stock with overweight rating
09:54Enliven Therapeutics stock initiated at Overweight by JPMorgan